Wed, Aug 24, 2016
The shares of Aurobindo Pharma were trading over 6% on the BSE on Wednesday a day after the company reported a 23.81% growth in its consolidated net profit at Rs 584.96 crore for the quarter-ended June 30, 2016.
More >
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
